WTC Pune is delighted to announce that we are creating new opportunities in India in the field of clinical trials and medical research.
WTC Pune, along with our partner Jehangir Hospital Group, is working with a US pharma company that provides breakthrough treatments in oncology and respiratory diseases to conduct clinical trials in India for one of their products.
The first clinical trial, that includes 200 subjects, is currently underway, with plans to expand the trial to 300 new subjects, and ultimately include trials in different geographies for up to 3000 subjects.
Our partner, Jehangir Hospital Group, is a multidisciplinary healthcare provider that operates a wide spectrum of wellness and health-related businesses in India. The group has a dedicated facility to conduct Phase I to Phase IV clinical trials. With over twelve years of experience in medical research and clinical trials, Jehangir Hospital Group is one of the most experienced investigator sites in India and has broad expertise in managing clinical trial programs. Their clients include some of the most illustrious brands in the pharma world - such as, Pfizer, Roche, Novartis, Abbott and Merck.
With India emerging as a big clinical research and trial research hub for global pharma, WTC Pune is looking for companies that are in need of an India-based research and trial partner. To express your interest, or to initiate any discussions on the subject, please contact Riddhi Patani at firstname.lastname@example.org.